Next Generation Sequencing Market-Top Key Players Roche Holding Ag, Qiagen N.V., Knome, Inc., Perkinelmer, Inc., Partek, Inc. Among Other Report Forecast to 2022

According to Research for Markets, the Global Next Generation Sequencing market is estimated at $3.41 billion in 2015 and is expected to reach $13.50 billion by 2022 growing at a CAGR of 21.73% from 2015 to 2022. The growing adoption of sequencing technologies in clinical applications and low cost DNA sequencing are likely to drive the market growth. However, factors such as accuracy and standardization issues and lack of skilled labor are inhibiting the market growth. The rise in personalize medicine and cloud computing are likely to create more opportunities for this market during the forecast period.

Looking for more information on this market? Get Free sample report @ http://www.researchformarkets.com/sample/next-generation-sequencing-global-market-4554

In technology, Next Generation Sequencing sequencing by synthesis (SBS) segment is anticipated to move with a highest CAGR during forecast period. Diagnostics in application segment holds the largest share and is expected to grow at highest CAGR during forecast period. Research institutions held the largest market share in end user segment. North America dominates the global next generation sequencing market followed by Europe owing to rising government support towards research and development. Asia pacific is expected to grow at a faster rate during the forecast period due to the unmet market demand and increasing investments for development of healthcare.

Some of the key players in the market include Roche Holding Ag, Qiagen N.V., Knome, Inc., Perkinelmer, Inc., Partek, Inc., Pacific Biosciences, Oxford Nanopore Technologies, Ltd., Macrogen Inc., Life Technologies Corporation, Illumina, Inc., Genomatix Software GmbH, GATC Biotech Ag., Eurofins Scientific, DNASTAR Inc., Biomatters, Ltd., Beijing Genomics Institute and Agilent Technologies, Inc.

Technologies Covered:

• Sequencing By Ligation (SBL)
• Single-Molecule Real-Time Sequencing (SMRT)
• Sequencing By Synthesis (SBS)
• Pyrosequencing
• ION Semiconductor Sequencing
• Other Technologies

End Users Covered:

• Hospitals and clinics
• Biotech & Pharma Firms
• Research institutions
• Other End Users

Applications Covered:

• Personalized medicines
• Drug Discovery
• Diagnostics
• Agriculture & Animal Research
• Prenatal Testing
• Biomarker Discovery
• HLA Testing
• Infectious Diseases
• Genetic Screening
• Oncology
• Idiopathic Diseases
• Other Applications

What our report offers:

- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Know More About our Knowledge store @ http://www.researchformarkets.com/reports/next-generation-sequencing-
global-market-4554

Short review On Table Of Content-

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 End User Analysis
3.8 Application Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Next Generation Sequencing Market, By Platforms
5.1 Introduction
5.2 Sequencing Services
5.2.1 Exome Sequencing
5.2.2 Methyl- Sequencing
5.2.3 Targeted Re-Sequencing
5.2.4 Whole-Genome Sequencing
5.2.5 De Novo Sequencing
5.2.6 Chip- Sequencing
5.2.7 RNA- Sequencing
5.2.8 Other Sequencing Services
5.3 Sequencing Platforms
5.3.1 Thermo Fisher Scientific (Life Technologies)
5.3.1.1 ION Torrent Platforms
5.3.1.1.1 ION S5 & S5 Xl
5.3.1.1.2 ION PGM
5.3.1.1.3 ION Proton
5.3.1.2 Solid Series
5.3.2 Pacific Biosciences
5.3.2.1 Sequel System
5.3.2.2 Pacbio Rs Ii
5.3.3 Illumina
5.3.3.1 Hiseq X Ten & Hiseq X Five
5.3.3.2 Nextseq500
5.3.3.3 Hiseq Series
5.3.3.4 Miseq Series
5.3.4 Other Sequencing Platforms

6 Global Next Generation Sequencing Market, By Technology
6.1 Introduction
6.2 Sequencing By Ligation (SBL)
6.3 Single-Molecule Real-Time Sequencing (SMRT)
6.4 Sequencing By Synthesis (SBS)
6.5 Pyrosequencing
6.6 ION Semiconductor Sequencing
6.7 Other Technologies

7 Global Next Generation Sequencing Market, By End User
7.1 Introduction
7.2 Hospitals and clinics
7.3 Biotech & Pharma Firms
7.4 Research institutions
7.5 Other End Users

8 Global Next Generation Sequencing Market, By Application
8.1 Introduction
8.2 Personalized Medicines
8.3 Drug Discovery
8.4 Diagnostics
8.5 Agriculture & Animal Research
8.8 Prenatal Testing
8.7 Biomarker Discovery
8.8 HLA Testing
8.9 Infectious Diseases
8.10 Genetic Screening
8.11 Oncology
8.12 Idiopathic Diseases
8.13 Other Applications

9 Global Next Generation Sequencing Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Roche Holding Ag
11.2 Qiagen N.V.
11.3 Knome, Inc.
11.4 Perkinelmer, Inc.
11.5 Partek, Inc.
11.6 Pacific Biosciences
11.7 Oxford Nanopore Technologies, Ltd.
11.8 Macrogen Inc.
11.9 Life Technologies Corporation
11.10 Illumina, Inc.
11.11 Genomatix Software GmbH
11.12 GATC Biotech Ag.
11.13 Eurofins Scientific
11.14 DNASTAR Inc.
11.15 Biomatters, Ltd.
11.16 Beijing Genomics Institute
11.17 Agilent Technologies, Inc.

If you have any special requirements, please let us know and we will offer you the report as you want.
Buy Now This Report Directly Follow@ http://www.researchformarkets.com/buy-now/next-generation-sequencing-global-market-4554/one

About Us:

Research For Markets indulge in detailed and diligent research on different markets, trends and emerging opportunities in the successive direction to cater to your business needs. We have established the pillars of our flourishing institute on the grounds of Credibility and Reliability. RFM delve into the markets across Asia Pacific, North America, South America, Europe, Middle East And Africa.

Contact Us:

Mr. A Naidu

Research for Markets

Email: alan.naidu@researchformarkets.com

+44 8000-4182-37

This release was published on openPR.